FW Medical Ltd.
- Company typePrivate
- Founded2007
- HeadquartersGlasgow, United Kingdom
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
FW Medical Ltd. firmographics
Firmographics- Name
- FW Medical Ltd.
- Legal name
- FW Medical Ltd
- Website
- https://fwmedical.co.uk
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
FW Medical Ltd. industry classification
Industry- Product category
- Consumer Healthcare / Medical Devices
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Gastrointestinal & Digestive Health (HLAIADAD)
- akta.pro secondary industry
- Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC) (CRADAMAE)
Keywords
Where FW Medical Ltd. is headquartered
LocationHeadquarters
- HQ city
- Glasgow
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
FW Medical Ltd. business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D
Revenue model
- UK Distribution & Marketing Partnership: Strategic UK commercial partnership for healthcare brands entering the British market. Provides sales operations, key account management, retail access, and regulatory support for brand distribution through UK retail partners.
- Global Export Distribution: Export of silicol®gel through pharmaceutical distributors and healthcare partners to international markets. Work closely with Distributor Partners from market registration through to product launch and ongoing in-market support.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
FW Medical Ltd. product offering
Product offeringCore offering
FW Medical Ltd manufactures, distributes and markets two consumer healthcare products — silicol®gel (a Class IIb Medical Device in liquid oral gel form for gastrointestinal disorders and IBS symptoms such as diarrhoea, abdominal pain, bowel discomfort and flatulence) and silicol®skin (a topical skincare product for problem skin). The company also operates as a UK Sales & Marketing Partner for European healthcare brands entering the British market, providing retail access, key account management, and MHRA regulatory support.
Product overview
FW Medical Ltd is a British consumer healthcare company that distributes and markets a portfolio of two core medical/healthcare products: silicol®gel (a Class IIb Medical Device for treating gastrointestinal disorders and IBS symptoms) and silicol®skin (a skincare product for problem skin). Both products share the key ingredient colloidal silica/silicic acid, which provides their therapeutic mode of action by physically binding and adsorbing irritants and toxins. The company serves as a UK sales and marketing partner for these brands, handling distribution through UK retailers (Amazon, Boots, Holland & Barrett, Sainsbury's, Superdrug, Tesco) and exporting to over 22 countries globally.
Differentiator
Problem solved
Functional benefit
Brands
- silicol®gel: A clinically proven liquid oral gel used to treat gastrointestinal disorders and IBS symptoms such as Diarrhoea, Abdominal Pain, Bowel Discomfort and Flatulence. A Class IIb Medical Device consisting of colloidal silicic acid.
- silicol®skin
Products and services
- silicol®gel A clinically proven liquid oral gel (Class IIb Medical Device) consisting of colloidal silicic acid, used to treat gastrointestinal disorders and IBS symptoms including diarrhoea, abdominal pain, bowel discomfort, and flatulence. Its mode of action forms a protective and soothing coating over the stomach and intestinal lining, binding irritants and toxins for natural elimination. Targeted at adult consumers seeking OTC gastrointestinal relief.
- silicol®skin A topical skincare product containing colloidal silica as its key ingredient, designed to physically bind irritants, impurities, and bacteria from the skin to address problem skin conditions. The formulation is alcohol, perfume, and paraben free. Targeted at consumers seeking a gentle treatment for problem skin.
- UK Sales & Marketing Partnership A strategic UK commercial partnership service for healthcare brands entering the British market, providing consumer and digital advertising support, sales operations, key account management, established trade connections, retail access (Amazon, Boots, Holland & Barrett, Sainsbury's, Superdrug, Tesco), and MHRA regulatory support including product registration. Targeted at European healthcare brand owners lacking UK infrastructure.
Quantifiable outcome
- Successfully launched and distributed European brands in multiple countries achieving leading category positions
Companies that use FW Medical Ltd.
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
FW Medical Ltd. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
FW Medical Ltd. partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and supporting.
- UK Retail Partners (Boots, Holland & Barrett, Sainsbury's, Superdrug, Tesco)coreEstablished network of UK retail partners for distribution of silicol®gel and silicol®skin products. Major pharmacy and health food retail chains providing retail access across the UK market.
- Amazon UKcoreOnline marketplace partner for silicol®gel and silicol®skin product sales in the UK market.
- International Pharmaceutical DistributorscoreNetwork of pharmaceutical distributors and healthcare partners exporting silicol®gel to over 22 countries across Europe, Middle East, South Africa, Southeast Asia, and Australia. FW Medical works closely with distributors from market registration through to product launch and ongoing in-market support.
- Contract Manufacturers, Agencies, and Logistics ProviderssupportingPartners providing manufacturing, agency services, and logistics for product operations. Referenced as part of the strong and reliable partner network contributing to company success.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
FW Medical Ltd. competitors and assessment
Company assessmentDirect peers
- Bio-Kult: UK probiotics and gut-health brand distributed through pharmacies, health-food stores and grocery. Overlaps with FW Medical's digestive-health category and UK retail footprint.
- Symprove: UK-based gut-health product targeting IBS and digestive issues. Directly comparable therapeutic area to silicol®gel and similar UK retail and online distribution.
- Biocare: UK specialist health supplements and gut-health brand selling through health-food and pharmacy channels including Holland & Barrett. Comparable as a UK-headquartered consumer healthcare brand with overlapping retail and digestive-health positioning.
- PrecisionBiotics (Alflorex): Ireland/UK-based probiotics brand targeting IBS and digestive health. Directly comparable category overlap with silicol®gel's gastrointestinal/IBS positioning and similar pharmacy and grocery distribution routes.
- Healthspan: UK direct-to-consumer vitamins, minerals and supplements brand. Comparable as a UK consumer healthcare business selling through own site, mail order and retail channels including Holland & Barrett.
- Ceuta Healthcare: UK-based sales, marketing and distribution partner for consumer healthcare and OTC brands. Highly comparable to FW Medical's role as a UK commercial partner for European healthcare brands and its multi-channel retail distribution model.
- Protexin: UK-based probiotics and gut-health brand (now part of ADM) sold through UK pharmacies and health stores. Directly comparable category and channel overlap with silicol®gel.
Emerging players
- BetterYou: UK specialist in transdermal vitamin and mineral supplementation. Comparable as a smaller UK consumer health brand with own e-commerce and selective health-retail listings, sharing the silicol®skin retail channels.
Broad incumbents
- Bayer Consumer Health (Buscopan): Global OTC player with Buscopan for abdominal/IBS-type symptoms. Overlaps with silicol®gel's gastrointestinal therapeutic area and UK pharmacy distribution.
- Reckitt Benckiser (Nurofen, Gaviscon): Global OTC consumer health major with leading digestive-health (Gaviscon) and pain relief brands. Comparable as a broad incumbent competing in the same UK pharmacy and grocery aisles where silicol®gel is sold.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
FW Medical Ltd. social profiles
Digital presenceFW Medical Ltd. compliance and trust
Trust signalCompliance2 records
FW Medical Ltd. financial estimates
Financial estimateRevenue estimate
Valuation estimate
FW Medical Ltd. leadership team
Management profileNumber of profiles
Profiles4 records
FW Medical Ltd. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FW Medical Ltd. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FW Medical Ltd.
What does FW Medical Ltd. do?
FW Medical Ltd manufactures, distributes and markets two consumer healthcare products — silicol®gel (a Class IIb Medical Device in liquid oral gel form for gastrointestinal disorders and IBS symptoms such as diarrhoea, abdominal pain, bowel discomfort and flatulence) and silicol®skin (a topical skincare product for problem skin). The company also operates as a UK Sales & Marketing Partner for European healthcare brands entering the British market, providing retail access, key account management, and MHRA regulatory support.
Is FW Medical Ltd. a public or private company?
FW Medical Ltd. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was FW Medical Ltd. founded?
FW Medical Ltd. was founded in 2007. It employs 1 to 10 people.
Where is FW Medical Ltd. based?
FW Medical Ltd. is headquartered in Glasgow, United Kingdom, in the Europe region.
How does FW Medical Ltd. make money?
Two revenue lines are on record. UK Distribution & Marketing Partnership is the primary driver. The others are global Export Distribution.
Who are FW Medical Ltd.'s main competitors?
Direct peers on record are Bio-Kult, Symprove, Biocare, PrecisionBiotics (Alflorex), Healthspan, Ceuta Healthcare and Protexin. BetterYou is listed as an emerging player. Broad incumbents are Bayer Consumer Health (Buscopan) and Reckitt Benckiser (Nurofen, Gaviscon).
Does FW Medical Ltd. have an API?
No public API is recorded for FW Medical Ltd..
What industry is FW Medical Ltd. in?
FW Medical Ltd.'s product category is Consumer Healthcare / Medical Devices. Its primary akta.pro industry code is HLAIADAD, Gastrointestinal & Digestive Health, with a secondary code of CRADAMAE, Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC). Its NAICS code is 42421 and its SIC code is 2834.